Regulation of mTOR and cell growth in response to energy stress by REDD1

Avi Sofer1, Kui Lei, Cory M Johannessen

  • 1Massachusetts General Hospital Cancer Center and Harvard Medical School, GRJ-904, 55 Fruit Street, Boston, Massachusetts 02114, USA.

Insights

The stress response gene REDD1 controls cell growth by inhibiting the mTOR pathway during energy depletion. This finding reveals REDD1 as a key regulator in the tuberous sclerosis complex-mTOR signaling pathway.

Area of Science:

  • Cellular Biology
  • Molecular Biology
  • Biochemistry

Background:

  • The tuberous sclerosis tumor suppressors TSC1 and TSC2 are critical regulators of the mechanistic target of rapamycin (mTOR) pathway, controlling cell growth and translation.
  • The REDD1 gene was previously identified as a mediator of TSC-dependent mTOR regulation by hypoxia.

Purpose of the Study:

  • To investigate the role of REDD1 in mediating the cellular response to energy stress through the TSC-mTOR pathway.
  • To elucidate the mechanism by which REDD1 regulates mTOR function during energy depletion.

Main Methods:

  • Utilized REDD1 knockout (REDD1-/-) cells and cells with tetracycline-inducible REDD1 expression.
  • Assessed mTOR substrate phosphorylation (S6K, 4E-BP1) following ATP depletion or AMP-activated protein kinase (AMPK) activation.
  • Investigated the interaction with the TSC1/2 complex and Rheb.
  • Measured cellular size changes in response to REDD1 modulation and rapamycin treatment.

Main Results:

  • Endogenous REDD1 is induced by energy stress, and its absence impairs mTOR substrate dephosphorylation.
  • REDD1 inhibition of mTOR requires TSC2 and is independent of AMPK, but dependent on Rheb.
  • Inducible REDD1 expression decreases cell size, while REDD1 deficiency leads to defective growth regulation under energy stress.
  • Knockdown of REDD1 increases cell size in a rapamycin-sensitive manner.

Conclusions:

  • REDD1 acts as a crucial transducer of the cellular response to energy depletion via the TSC-mTOR pathway.
  • REDD1 directly inhibits mTOR signaling to control cell growth during periods of low energy availability.
  • These findings highlight REDD1 as a key player in cellular energy homeostasis and growth control.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...